Method of employing a balloon tube for creating a thrombosis of vessels located directly under the surface of a body cavity which is difficult to reach, through the initiation of an electric current between the balloon which is deflated as introduced into the body cavity and which is inflated by introducing a fluid on the spot and an outside electrode. The fluid which is used to inflate the balloon is electrically conductive and the balloon wall is semi-permeable for the fluid.

Patent
   RE39200
Priority
May 12 1989
Filed
Jan 17 1997
Issued
Jul 18 2006
Expiry
May 03 2010
Assg.orig
Entity
Large
0
41
EXPIRED
0. 14. An apparatus for treating a blood vessel comprising:
a tube including an inlet and outlet, the tube adapted to receive a conductive fluid;
a balloon in communication with a portion of the tube, the balloon including a membrane adapted to allow the conductive fluid to pass through the membrane;
an electrode adapted to be located outside the blood vessel; and
an electronically conductive wire adapted to connect the electrode to the conductive fluid.
0. 1. Method for creating a thrombosis in a blood vessel located directly under the surface of a body cavity which is difficult to reach comprising
inserting a deflated balloon containing a cylindrical tube into the body cavity, the tube having openings to the balloon,
inflating the balloon by introducing an electrically conductive fluid into the tube, the balloon having an exterior wall semi-permeable to the fluid, contacting a conductive wire to the conductive fluid to provide a connection to an electrode outside the body and initiating an electric current between the balloon and the electrode located outside the body cavity.
0. 2. The method according to claim 1 wherein a wire is inserted through the cylindrical tube and is connected to the electrode located outside the body cavity.
0. 3. The method according to claim 2 wherein the wire inserted is made of platinum.
0. 4. The method according to claim 3 wherein the fluid introduced is normal saline solution.
0. 5. The method according to claim 2 wherein the fluid introduced is normal saline solution.
0. 6. The method according to claim 1 wherein the fluid introduced is normal saline solution.
0. 7. The method according to claim 6, the method further comprising a step of adding a medicament to the fluid.
0. 8. The method according to claim 1, the method further comprising a step of adding a medicament to the fluid.
0. 9. An apparatus for inducing thrombosis in hard to reach blood vessels within a living body comprising
a cylindrical tube having multiple lateral passage-ways,
an electrically conductive fluid located within the tube,
a balloon having a membrane wall semipermeable to the fluid surrounding a portion of the cylindrical tube containing the passageways,
a counter electrode adapted to be located outside the body and
an electrically conductive wire electrically connecting the fluid and the electrode.
0. 10. An apparatus according to claim 9 wherein the fluid is normal saline solution.
0. 11. An apparatus according to claim 9 wherein the wire is made of platinum and the fluid is normal saline solution.
0. 12. An apparatus according to claim 11 wherein a medicament is present in the fluid.
0. 13. An apparatus according to claim 9 wherein a medicament is present in the fluid.
0. 15. The apparatus of claim 14 wherein the electrode is adapted to be located outside the body.
0. 16. The apparatus of claim 14 wherein the balloon is semi-permeable.
0. 17. The apparatus of claim 14 wherein the conductive wire extends through the tube.
0. 18. The apparatus of claim 14 wherein the wire is platinum.
0. 19. The apparatus of claim 14 wherein the balloon is made of a material which offers no significant electrical resistance.
0. 20. The apparatus of claim 14 wherein the tube is made of a material which offers significant electric resistance.

This is a Continuation Reissue Application of Ser. No. 08/120,212, filed Sep. 10, 1993, now Reissue No. 35,775, which is a Reissue of Application of Ser. No. 07/518,163, filed May 3, 1990, now U.S. Pat. No. 5,047,028.

1. Field of the Invention

This invention relates to methods employing balloon tubes in medical practice. More particularly, the invention concerns a method of using a balloon tube for inducing thrombosis in blood vessels located directly under the surface of a cavity in the body which is difficult to reach.

2. Description of the Prior Art

Balloon tubes are known from T. V. Taylor and J. M. M. Neilson's article “Currents and Clots” —an approach to the problem of acute variceal bleeding”. Br. J. Surg. Vol. 68 (1981) 692-696. It is known how to stop bleeding of vessels located directly under the surface of a difficult to reach body cavity, through thrombosis by introducing a deflated balloon tube into the body cavity and then inflating it by applying a fluid at the correct position. The balloon tube from the previous proposal is furnished with electrodes on its outer surface. These electrodes are supplied with a voltage across an electrically conductive wire. An electrode, possibly placed on the patient's back, can serve as an oppositely charged electrode. The electric current which arises through the application of voltage between the two electrodes induces thrombosis and therefore acts to stop the bleeding of the vessels.

Such thrombosis in bleeding vessels is indicated especially for oesophageal varices but could also be involved in bleeding in other body cavities.

The balloon tube which is known from the above-named article has not been able to assert itself in practice, since the resistance between the electrode and the surface of the body cavity is not defined.

The aim of the invention is to further develop the balloon tube as it is already known, so that it suffices for the demands of practical use.

Through this invention this problem can be solved by the fact that the fluid which serves to inflate the balloon is capable of carrying in an electric current and the membrane wall of the balloon is semi-permeable for the fluid.

The wire, which is to be led through the tube, should preferably be made of platinum.

Normal saline solution can be used as the fluid. Other electrically conductive fluids, such as electrode gel, can be used. The fluid can also serve as a conductor of medication.

The invention is explained by the following description and drawings in which:

FIG. 1 shows a cross-section through the balloon tube, whereby the upper part of the tube has been cut off and

FIG. 2 shows a cross-section along the line II—II from FIG. 1.

Throughout the following detailed description, the same reference numerals refer to the same elements in all figures.

The balloon tube which has been used corresponds in its appearance at first glance to a normal Sengstaken-Tube. It consists of a tube 10 and a balloon 12 located near the end of tube 10. Tube 10 is furnished with openings 14 in the area in which the tube 10 is led through balloon 12. A conductive wire 16 is led through tube 10. Preferably, the conductive wire is made from platinum.

As an example, to stop bleedings of the oesophageal varices, the balloon tube is introduced into the oesophagus, whereby balloon 12 is deflated. When the desired place has been reached, a conductive fluid, for example, normal saline solution, is introduced into the tube 10. The fluid enters balloon 12 through the openings 14 in tube 10 and fills it. The balloon membrane walls 18 are of a semipermeable nature. Therefore, a small amount of the conducting fluid flows through the balloon walls 18. The balloon wall 18 offers no significant electrical resistance.

A counter electrode 20 with a large surface is applied to the chest area of the patient in the case of thrombosis of oesophageal varices.

By applying a source of voltage between the platinum wire 16 and the counter electrode 20 with opposite charge, a current arises between these two which induces the desired thrombosis through the choice of a suitable voltage difference between them.

The special wire 16 is not absolutely necessary, but rather the conductive fluid found in the tube also can be used as an electric conductor. Tube 10 is not semi-permeable and therefore offers considerable electric resistance.

Instead of a normal saline solution, a substance such as electrode gel, for example, also can be used as a conducting fluid.

The balloon tube suggested here can further be used for example for the treatment of post-operative rebleedings after urethra operations or by lower intestinal bleedings or also by nasopharyngeal bleedings.

A further method is to add medications to the conducting fluid which induce blood-stanching over an iontophoretic tissue diffusion.

Qian, Quinghua

Patent Priority Assignee Title
Patent Priority Assignee Title
2123980,
3411507,
3618601,
3716054,
3991755, Jul 27 1973 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
4250878, Nov 22 1978 IOMED, INC A CORP OF UT Non-invasive chemical species delivery apparatus and method
4309989, Feb 09 1976 FAHIM, MOSTAFA, S , Topical application of medication by ultrasound with coupling agent
4383529, Nov 03 1980 Wescor, Inc. Iontophoretic electrode device, method and gel insert
4405311, Dec 08 1980 GREATBATCH ENTERPRISES, INC Method and apparatus for direct electrical injection of gold ions into tissue such as bone
4411648, Jun 11 1981 Board of Regents, The University of Texas System Iontophoretic catheter device
4506680, Mar 17 1983 Medtronic, Inc.; MEDTRONIC, INC , A CORP OF MN Drug dispensing body implantable lead
4522205, Sep 03 1980 Bard Limited Therapeutic device and method of inducing thrombosis in a blood vessel
4569673, Jan 12 1984 BRIDGE BLOOD TECHNOLOGIES LLC, NEW YORK LIMITED LIABILITY COMPANY Bacterial barrier for indwelling catheters and other medical devices
4574807, Mar 02 1984 BRUNSWICK BIOMEDICAL TECHNOLOGIES, INC , A MA CORP Method and apparatus for pacing the heart employing external and internal electrodes
4577642, Feb 27 1985 Medtronic, Inc. Drug dispensing body implantable lead employing molecular sieves and methods of fabrication
4717381, May 13 1985 Kos Medical Technologies, Ltd. Hydrodynamically propelled catheter
4752285, Mar 19 1986 UNIVERSITY OF UTAH RESEARCH FOUNDATION, THE, SALT LAKE CITY, UT A CORP OF UT Methods and apparatus for iontophoresis application of medicaments
4767402, Jul 08 1986 Massachusetts Institute of Technology Ultrasound enhancement of transdermal drug delivery
4776349, Oct 04 1985 Tubular device for the treatment of hollow organs with electric current
4877031, Jul 22 1988 Advanced Cardiovascular Systems, Inc. Steerable perfusion dilatation catheter
4892519, Dec 03 1987 Advanced Cardiovascular Systems, Inc. Steerable perfusion dilatation catheter
4915685, Mar 19 1986 IOMED, INC Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
4944745, Feb 29 1988 Boston Scientific Scimed, Inc Perfusion balloon catheter
4960133, Nov 21 1988 BRUNSWICK BIOMEDICAL TECHNOLOGIES, INC , A MA CORP Esophageal electrode
4979948, Apr 13 1989 PURDUE RESEARCH FOUNDATION, WEST LAFAYETTE, IN A CORP OF IN Method and apparatus for thermally destroying a layer of an organ
4994033, May 25 1989 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Intravascular drug delivery dilatation catheter
5135477, Oct 29 1984 ALZA CORPORATION, A CORPORATION OF DE Iontophoretic drug delivery
578611,
600290,
791730,
866180,
873021,
DE3516830,
DE3809815,
EP438078,
EP119296,
RU1069826,
RU1069827,
RU322202,
RU843999,
WO9119529,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 17 1997Boston Scientific Scimed, Inc.(assignment on the face of the patent)
Dec 22 2004SciMed Life Systems, INCBoston Scientific Scimed, IncCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0165530601 pdf
Date Maintenance Fee Events
Jun 28 2005ASPN: Payor Number Assigned.


Date Maintenance Schedule
Jul 18 20094 years fee payment window open
Jan 18 20106 months grace period start (w surcharge)
Jul 18 2010patent expiry (for year 4)
Jul 18 20122 years to revive unintentionally abandoned end. (for year 4)
Jul 18 20138 years fee payment window open
Jan 18 20146 months grace period start (w surcharge)
Jul 18 2014patent expiry (for year 8)
Jul 18 20162 years to revive unintentionally abandoned end. (for year 8)
Jul 18 201712 years fee payment window open
Jan 18 20186 months grace period start (w surcharge)
Jul 18 2018patent expiry (for year 12)
Jul 18 20202 years to revive unintentionally abandoned end. (for year 12)